Stay updated on NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.

Latest updates to the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check25 days agoChange DetectedAn NIH banner announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference0.4%

- Check32 days agoChange DetectedThe website revision changed from v3.7.1 to v3.7.2; the clinical trial record information remains unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry v3.7.0 has been added to the history, and the previous revision v3.6.6 has been removed, updating the version history for the page.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry v3.6.6 was added to the study history, replacing the previous v3.6.5 entry. This reflects a small update to the study record.SummaryDifference0.1%

Stay in the know with updates to NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.